6/17
12:16 pm
nvno
New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024 [Yahoo! Finance]
Low
Report
New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024 [Yahoo! Finance]
6/17
12:00 pm
nvno
New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024
Low
Report
New Interim Venous Ulcer Healing Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the Society for Vascular Surgery 2024 Vascular Annual Meeting on June 21, 2024
5/8
04:23 pm
nvno
enVVeno Medical Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
Low
Report
enVVeno Medical Reports First Quarter 2024 Financial Results and Provides Corporate Update [Yahoo! Finance]
5/8
04:15 pm
nvno
enVVeno Medical Reports First Quarter 2024 Financial Results and Provides Corporate Update
Low
Report
enVVeno Medical Reports First Quarter 2024 Financial Results and Provides Corporate Update
4/24
06:24 am
nvno
Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve(R) Pivotal Trial to be Presented Today at the 46th Annual Charing Cross Symposium [Yahoo! Finance]
High
Report
Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve(R) Pivotal Trial to be Presented Today at the 46th Annual Charing Cross Symposium [Yahoo! Finance]
4/24
06:15 am
nvno
Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve(R) Pivotal Trial to be Presented Today at the 46th Annual Charing Cross Symposium
Medium
Report
Positive 11 Month Topline Efficacy Data Showing Significant Clinical Improvement from enVVeno Medical's VenoValve(R) Pivotal Trial to be Presented Today at the 46th Annual Charing Cross Symposium
4/16
09:23 am
nvno
New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024 [Yahoo! Finance]
Low
Report
New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024 [Yahoo! Finance]
4/16
09:00 am
nvno
New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024
Low
Report
New Topline Efficacy Data from the enVVeno Medical VenoValve(R) Pivotal Trial to be Presented at the 46th Annual Charing Cross Symposium on April 24, 2024
4/9
09:00 am
nvno
enVVeno Medical Appoints Andrew Cormack as Its Chief Commercial Officer [Yahoo! Finance]
Low
Report
enVVeno Medical Appoints Andrew Cormack as Its Chief Commercial Officer [Yahoo! Finance]
4/9
08:45 am
nvno
enVVeno Medical Appoints Andrew Cormack as Its Chief Commercial Officer
Low
Report
enVVeno Medical Appoints Andrew Cormack as Its Chief Commercial Officer